Orion, the Q4 revenue was approx. $90k which was approx. 50% lower than their reported Q3 revs of approx. $180K, and we know they didn't even do their Vytex soft launch in multiple mainstream retailers until Q1 of this year...so we should all definitely be expecting strong Q over Q growth from their Vytex division alone from here on out, and we should also be expecting a mind blowing increase on the already impressive YOY revenue growth of +1942%.
And exactly how impressive Vytex alone becomes is gonna depend on how rapid the Vytex growth curve now underway becomes, and how much traction kicks in if/when VYST implements potential mainstream advertising, along with securing a number of very impactful/relevant new contracts on a multitude of other proprietary Vytex product offerings coming out of extensive talks/testing. Tires and car seat cushions are 2 quick examples that come to mind from the 10-K that VYST specifically mentioned, and that's on top of all the products hinted at the bottom of the VYST euro patent PR that came out a couple of months ago mentioning other products, especially a product like shoes, that they could've already done extensive talks/testing with for example.
And then we have to consider their recent PR about going into production on the new Rx3000 units from their RxAir subsidiary company and consider that they wouldn't be going into production during this Q2 if there wasn't any demand right!
And Dr. Stone provided a great Q&A email a few weeks ago discussing the still burgeoning potential in VYST's Fluid Energy Conversion division as well...and he even hinted at some of the testing and talks that have occurred behind the scenes as FEC also prepares to transform out of extended R&D and into full fledged commercialization.
And finally just to wrap this post up since it's already after market...VYST's exact Holding's Company growth by acquisition model already suggests quite clearly that they may have a number of other key asset or company acquisition targets coming along right behind Rotmans...so it's definitely not just Rotmans that we should be focused on as the big asset/revenue value-driven booster acquisition upon us, because for all we know there's several more key targets coming along right after Rotmans that will soon be providing the market with a far better picture on why VYST believes they'll soon be in a favorable position to qualify for an eventual Nasdaq up listing towards summers end...we just don't know what other potential acquisition targets exist yet, because right now the focus appears to be on closing Rotmans, as well it should right, cheers!
News 
Market Data 
Discover 
AI
